In the chronic setting, excessive SAA production is a precursor to secondary amyloidosis that can cause serious complications [24], and amyloid deposits can also accumulate within the brains of patients with systemic amyloidosis, particularly around circumventricular organs that lack a contiguous BBB [25]. Here, SAA1 is linked to primary systemic amyloidosis.